Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells

J Biol Chem. 2015 Feb 27;290(9):5449-61. doi: 10.1074/jbc.M114.600692. Epub 2015 Jan 7.

Abstract

Sepsis-mediated endothelial Angiopoeitin-2 (Ang2) signaling may contribute to microvascular remodeling in the developing lung. The mechanisms by which bacterial cell wall components such as LPS mediate Ang2 signaling in human pulmonary microvascular endothelial cells (HPMECs) remain understudied. In HPMEC, LPS-induced Ang2, Tie2, and VEGF-A protein expression was preceded by increased superoxide formation. NADPH oxidase 2 (Nox2) inhibition, but not Nox4 or Nox1 inhibition, attenuated LPS-induced superoxide formation and Ang2, Tie2, and VEGF-A expression. Nox2 silencing, but not Nox4 or Nox1 silencing, inhibited LPS-mediated inhibitor of κ-B kinase β (IKKβ) and p38 phosphorylation and nuclear translocation of NF-κB and AP-1. In HPMECs, LPS increased the number of angiogenic tube and network formations in Matrigel by >3-fold. Conditioned media from LPS-treated cells also induced angiogenic tube and network formation in the presence of Toll-like receptor 4 blockade but not in the presence of Ang2 and VEGF blockade. Nox2 inhibition or conditioned media from Nox2-silenced cells attenuated LPS-induced tube and network formation. Ang2 and VEGF-A treatment rescued angiogenesis in Nox2-silenced cells. We propose that Nox2 regulates LPS-mediated Ang2-dependent autocrine angiogenesis in HPMECs through the IKKβ/NF-κB and MAPK/AP-1 pathways.

Keywords: Angiogenesis; Angiopoeitin-2; Endothelial Cell; LPS; Lung Injury; NADPH Oxidase.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Angiopoietin-2 / genetics
  • Angiopoietin-2 / metabolism*
  • Animals
  • Cells, Cultured
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Endothelial Cells / physiology
  • Gene Expression / drug effects
  • Humans
  • I-kappa B Kinase / metabolism
  • Immunoblotting
  • Lipopolysaccharides / pharmacology*
  • Lung / blood supply
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Mice, Inbred C57BL
  • Microscopy, Fluorescence
  • Microvessels / cytology
  • NADPH Oxidase 2
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism*
  • NF-kappa B / metabolism
  • Neovascularization, Physiologic / drug effects*
  • Phosphorylation / drug effects
  • RNA Interference
  • Receptor, TIE-2 / genetics
  • Receptor, TIE-2 / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Transcription Factor AP-1 / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Angiopoietin-2
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • NF-kappa B
  • Transcription Factor AP-1
  • Vascular Endothelial Growth Factor A
  • CYBB protein, human
  • NADPH Oxidase 2
  • NADPH Oxidases
  • Receptor, TIE-2
  • I-kappa B Kinase
  • p38 Mitogen-Activated Protein Kinases